Company Analysis
Sign in

Revvity, Inc. (RVTY)

NYSE: RVTY · Laboratory Analytical Instruments · Waltham, MA · filing with the SEC since 1994
Full chart Alerts Compare
Grade6.2
◀ Past 6.6● Present 7.0▶ Future 4.9
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

1,361 patents granted to the 42 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Revvity, Inc.’s names, not what it holds today.

Patents granted
1,361
1,338 utility, 18 design, 5 reissue, 1976 to Dec 31, 2025
Granted in 2025
32
Against 14 in 2024 and 17 in 2023
Applications published
678
30 of them in 2025
Names they are printed under
42
a former name, a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Analysis of biological materials20
Measurement14
Chemical engineering12
Computer technology9
Biotechnology8
Pharmaceuticals8
Organic fine chemistry6
Optics4
Macromolecular chemistry, polymers2
Environmental technology2
Medical technology2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name42 counted
PerkinElmer, Inc. a former name
US, as the owner printed on each patent. 24 more under the same name are not counted (printed in GB)
781 granted
27 published
Dharmacon, Inc. a subsidiary
US, as the owner printed on each patent
115 granted
236 published
WALLAC OY a subsidiary
FI, as the owner printed on each patent. 2 more under the same name are not counted (printed in PH, printed in US)
127 granted
60 published
EUROIMMUN Medizinische Labordiagnostika AG a subsidiary
DE, as the owner printed on each patent. 1 more under the same name are not counted (printed in GB)
78 granted
80 published
Xenogen Corporation a subsidiary
US, as the owner printed on each patent
67 granted
52 published
Cambridge Research & Instrumentation, Inc. a subsidiary
US, as the owner printed on each patent
64 granted
21 published
VisEn Medical, Inc. a subsidiary
US, as the owner printed on each patent
39 granted
16 published
BioLegend, Inc. a subsidiary
US, as the owner printed on each patent
11 granted
14 published
OMNI INTERNATIONAL, INC. a subsidiary
US, as the owner printed on each patent
13 granted
11 published
WALLAC OY a subsidiary
named as the applicant on its applications, in FI
0 granted
22 published
Immunetics, Inc. a subsidiary
US, as the owner printed on each patent
13 granted
8 published
CISBIO BIOASSAYS a subsidiary
FR, as the owner printed on each patent
8 granted
8 published
REVVITY HEALTH SCIENCES, INC. a subsidiary
US, as the owner printed on each patent
16 granted
0 published
Vanadis Diagnostics a subsidiary
named as the applicant on its applications, in SE
0 granted
16 published
BioLegend, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
14 published
CISBIO BIOASSAYS a subsidiary
named as the applicant on its applications, in FR
0 granted
14 published
VANADIS DIAGNOSTICS a subsidiary
SE, as the owner printed on each patent
14 granted
0 published
Revvity Health Sciences, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
13 published
VisEn Medical, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
13 published
EUROIMMUN Medizinische Labordiagnostika AG a subsidiary
named as the applicant on its applications, in DE
0 granted
12 published
Oxford Immunotec Limited a subsidiary
GB, as the owner printed on each patent
5 granted
3 published
ViaCord LLC a subsidiary
US, as the owner printed on each patent
3 granted
2 published
Cambridge Research & Instrumentation, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
4 published
IMMUNODIAGNOSTIC SYSTEMS FRANCE a subsidiary
FR, as the owner printed on each patent
3 granted
1 published
Immunetics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
4 published
Revvity Cellular Technologies GmbH a subsidiary
named as the applicant on its applications, in DE
0 granted
4 published
Dharmacon, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
3 published
IMMUNODIAGNOSTIC SYSTEMS LIMITED a subsidiary
GB, as the owner printed on each patent
2 granted
1 published
Oxford Immunotec Limited a subsidiary
named as the applicant on its applications, in GB
0 granted
3 published
PerkinElmer, Inc. a former name
named as the applicant on its applications, in US
0 granted
3 published
Cambridge Research and Instrumentation,Inc. a Massachusetts corporation a subsidiary
US, as the owner printed on each patent
0 granted
2 published
HORIZON GENOMICS GMBH a subsidiary
named as the applicant on its applications, in AT
0 granted
2 published
REVVITY GENE DELIVERY GMBH a subsidiary
named as the applicant on its applications, in DE
0 granted
2 published
Cambridge Research & Instrumentation, Inc., a Delaware corporation a subsidiary
US, as the owner printed on each patent
0 granted
1 published
PerkinElmer Inc. A Massachusetts Corporation a former name
US, as the owner printed on each patent
0 granted
1 published
REVVITY HOLDINGS, INC. a subsidiary
US, as the owner printed on each patent
1 granted
0 published
Revvity Cellular Technologies GmbH a subsidiary
DE, as the owner printed on each patent
1 granted
0 published
Revvity Discovery Limited a subsidiary
named as the applicant on its applications, in GB
0 granted
1 published
Revvity Holdings, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Sage Labs, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
ViaCord LLC a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Xenogen Corporation a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Names not counted (3)
Horizon Discovery, Inc.
Most of its patents print GB; this name counts in JP, US. 0 granted and 8 published under it are not counted.
Horizon Discovery, Inc.
Most of its patents print GB; this name counts in JP, US. 3 granted and 2 published under it are not counted.
Horizon Genomics GmbH
No country is printed for it. 0 granted and 1 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 16, 202512,496,577Pipetting apparatus and methodsChemical engineeringREVVITY HEALTH SCIENCES, INC.
Dec 2, 202512,487,168Systems and methods for cell count measurementsMeasurementREVVITY HEALTH SCIENCES, INC.
Dec 2, 202512,486,226Cannabinoid derivativesOrganic fine chemistryREVVITY HEALTH SCIENCES, INC.
Nov 25, 202512,480,877Method and apparatus for detecting a presence of a fluorescence pattern type on an organ section by means of immunofluorescence microscopyComputer technologyEUROIMMUN Medizinische Labordiagnostika AG
Nov 11, 202512,465,335Specimen collection and delivery apparatusMedical technologyREVVITY HEALTH SCIENCES, INC.
Nov 4, 202512,461,095Stable nanomagnetic particle dispersionsAnalysis of biological materialsBioLegend, Inc.
Oct 28, 202512,455,290Methods for detecting meteorin-β activityAnalysis of biological materialsBioLegend, Inc.
Oct 14, 202512,442,826Lateral flow test strip readers, cartridges and related methodsAnalysis of biological materialsWALLAC OY
Oct 14, 202512,442,823Method and reagents for diagnosing membranous nephropathyAnalysis of biological materialsEUROIMMUN Medizinische Labordiagnostika AG
Oct 14, 202512,441,806Anti-TLR9 agents and compositions and methods for making and using the samePharmaceuticalsBioLegend, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0388912MEANS FOR GENERATING ADENOVIRAL VECTORS FOR CLONING LARGE NUCLEIC ACIDSBiotechnologyREVVITY GENE DELIVERY GMBH
Dec 18, 20252025/0382358METHODS AND COMPOSITIONS RELATING TO MOUSE MONOCLONAL ANTI-G4S LINKER ANTIBODIESBiotechnologyBioLegend, Inc.
Nov 13, 20252025/0346611FLUORESCENT GTP ANALOGUES AND USEOrganic fine chemistryCISBIO BIOASSAYS
Nov 6, 20252025/0341516COMPOSITIONS FOR USE WITH MULTIPLE FLUOROPHORES AND METHODS OF USINGMacromolecular chemistry, polymersBioLegend, Inc.
Nov 6, 20252025/0341514COMPOSITIONS FOR USE WITH MULTIPLE FLUOROPHORES AND METHODS OF USINGAnalysis of biological materialsBioLegend, Inc.
Oct 9, 20252025/0313650CHI3L1 BINDING ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOFAnalysis of biological materialsBioLegend, Inc.
Oct 2, 20252025/0308020METHOD FOR DETERMINING A FOCUSING MEASURE OF A MICROSCOPIC IMAGEComputer technologyEUROIMMUN Medizinische Labordiagnostika AG
Oct 2, 20252025/0304997POLYNUCLEOTIDES WITH SELECTION MARKERSBiotechnologyRevvity Discovery Limited
Sep 25, 20252025/0297156CONJUGATED POLYMERS AND METHODS OF USEMacromolecular chemistry, polymersBioLegend, Inc.
Jul 17, 20252025/0230485BARCODING OF NUCLEIC ACIDSBiotechnologyRevvity Holdings, Inc.
What it applied for, 2024 to 2025: Biotechnology 11 · Analysis of biological materials 9 · Chemical engineering 8 · Computer technology 8 · Measurement 4 · Organic fine chemistry 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton RVTY · research, not advice